Bruker (BRKR) Cash & Current Investments (2016 - 2025)
Bruker (BRKR) has disclosed Cash & Current Investments for 16 consecutive years, with $322.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments rose 66.2% year-over-year to $322.6 million, compared with a TTM value of $322.6 million through Dec 2025, up 66.2%, and an annual FY2025 reading of $322.6 million, up 66.2% over the prior year.
- Cash & Current Investments was $322.6 million for Q4 2025 at Bruker, up from $293.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $1.2 billion in Q4 2021 and bottomed at $92.0 million in Q2 2025.
- Average Cash & Current Investments over 5 years is $503.4 million, with a median of $531.6 million recorded in 2023.
- The sharpest move saw Cash & Current Investments skyrocketed 179.83% in 2021, then plummeted 64.89% in 2024.
- Year by year, Cash & Current Investments stood at $1.2 billion in 2021, then crashed by 44.74% to $645.5 million in 2022, then fell by 24.35% to $488.3 million in 2023, then crashed by 60.25% to $194.1 million in 2024, then soared by 66.2% to $322.6 million in 2025.
- Business Quant data shows Cash & Current Investments for BRKR at $322.6 million in Q4 2025, $293.1 million in Q3 2025, and $92.0 million in Q2 2025.